This invention relates to delivery of respiratory gases particularly though not solely to patient interfaces for providing gases to patients requiring respiratory therapy.
In the art of respiration devices, there are well known a variety of respiratory masks which cover the nose and/or mouth of a human user in order to provide a continuous seal around the nasal and/or oral areas of the face such that gas may be provided at positive pressure within the mask for consumption by the user. The uses for such masks range from high altitude breathing (i.e., aviation applications) to mining and fire fighting applications, to various medical diagnostic and therapeutic applications.
One requisite of such respiratory masks has been that they provide an effective seal against the user's face to prevent leakage of the gas being supplied. Commonly, in prior mask configurations, a good mask-to-face seal has been attained in many instances only with considerable discomfort for the user. This problem is most crucial in those applications, especially medical applications, which require the user to wear such a mask continuously for hours or perhaps even days. In such situations, the user will not tolerate the mask for long durations and optimum therapeutic or diagnostic objectives thus will not be achieved, or will be achieved with great difficulty and considerable user discomfort.
In common with prior art designs, is an inability to seal effectively when the user's face becomes distorted. For example, as shown in the prior art mask of
It is an object of the present invention to provide a nasal mask which goes some way to overcoming the abovementioned disadvantages in the prior art or which will at least provide the industry with a useful choice.
Accordingly in one aspect the invention consists in a device for delivering a supply of gases to a user comprising or including:
a patient interface, in use in fluid communication with said supply of gases,
securement means attached to or around the head of said user, and
engaging means adapted to slidingly engage said securement means with said patient interface.
In a second aspect the present invention consists in nasal mark for delivering gases to a user comprising or including:
a body portion having a inlet, in use said inlet receiving a supply of gases,
sealing means engaged with said body portion, and adapted to seal against the facial contours of said user, and
engaging means adapted to in use provide a sliding engagement with a means of securement to a user, and a compressive force on said sealing means to ensure said supply of gases is delivered to a user without significant leakage.
In a third aspect the present invention consists in a CPAP system for delivering gases to a user comprising or including a pressurised source of gases, transport means in fluid communication with said pressurised source adapted to convey said gases, and a patient interface in fluid communication with said transport means in use delivering said gases to said user, the improvement comprising that said patient interface adapted to sliding engage with a means of securement to a user, to ensure said supply of gases is delivered to a user without significant leakage.
To those skilled in the art to which the invention relates, many changes in construction and widely differing embodiments and applications of the invention will suggest themselves without departing from the scope of the invention as defined in the appended claims. The disclosures and the descriptions herein are purely illustrative and are not intended to be in any sense limiting.
The invention consists in the foregoing and also envisages constructions of which the following gives examples.
One preferred form of the present invention will now be described with reference to the accompanying drawings in which;
The present invention provides improvements in the field of patient interfaces for use in respiratory therapy. In particular an interface is described which is more comfortable for the user to wear and reduces the side leakage as compared with interfaces of the prior art. It will be appreciated that while a mask is described in the preferred embodiment, the present invention can be used in respiratory care generally or with a ventilator but will now be described below with reference to use in a humidified CPAP system. It will be appreciated the present invention could equally be used with any form of positive pressure respiratory therapy.
With reference to
Controller 9 receives input from sources such as user input means or dial 10 through which a user of the device may, for example, set a predetermined required value (preset value) of humidity or temperature of the gases supplied to patient 1. The controller may also receive input from other sources, for example temperature and/or flow velocity sensors 11 and 12 through connector 13 and heater plate temperature sensor 14. In response to the user set humidity or temperature value input via dial 10 and the other inputs, controller 9 determines when (or to what level) to energise heater plate 7 to heat the water 6 within humidification chamber 5. As the volume of water 6 within humidification chamber 5 is heated, water vapour begins to fill the volume of the chamber above the water's surface and is passed out of the humidification chamber 5 outlet 4 with the flow of gases (for example air) provided from a gases supply means or blower 15 which enters the chamber through inlet 16. Exhaled gases from the patient's mouth are passed directly to ambient surroundings in
Blower 15 is provided with variable pressure regulating means or variable speed fan 21 which draws air or other gases through blower inlet 17. The speed of variable speed fan 21 is controlled by electronic controller 18 (or alternatively the function of controller 18 could carried out by controller 9) in response to inputs from controller 9 and a user set predetermined required value (preset value) of pressure or fan speed via dial 19.
Nasal Mask
Referring to
The hollow body 102 is constructed of a relatively inflexible material for example, polycarbonate plastic. Such a material would provide the requisite rigidity as well as being transparent and a relatively good insulator. The expiratory gases can be expelled through a valve (not shown) in the mask, a further expiratory conduit (not shown), or any other such method as is known in the art
Mask Headgear
Referring now to
The advantage to this is as the face is contorted during various sleeping positions the headgear is able to move with the changes in position while the mask is left in the correct position on the nose of the user and an effective seal is maintained.
Additional guides 129, 130, 131 allow the user to adjust position of loop 120, giving ability to get different pressure on the seal depending on loop 120 position.
To further ensure user comfort and effective pressure on the mask cushion 104, the headgear 108 may be constructed either using two straps running around the back of the user's head as shown in
In a further embodiment shown in
As shown in
As shown in
In a further alternative the sliding loop or strap could form a continuous portion of the headgear. Other variations of the sliding connection are possible, for example a clip or knob in the loop or strap could slide withing slots in the mask body.
It will be appreciated that in all embodiments of the present invention the attachment from the headgear to the mask is designed to slide with the lowest possible friction while still ensuring adequate direct force on the mask cushion to the user's face. As shown in
Nasal Cannula
It will be appreciated that the present invention may be equally applied to any patient interface for delivery gases to a user.
Referring now particularly to
Full Face Mask
Referring to
Alternatively as seen in
Mouthpiece
Referring to
It will be appreciated that numerous other interfaces for example E.T (endrotraceal) tubes might also be used in conjunction with the present invention.
Number | Date | Country | Kind |
---|---|---|---|
505154 | Jun 2000 | NZ | national |
505155 | Jun 2000 | NZ | national |
505156 | Jun 2000 | NZ | national |
508218 | Nov 2000 | NZ | national |
508219 | Nov 2000 | NZ | national |
508433 | Nov 2000 | NZ | national |
509039 | Dec 2000 | NZ | national |
514184 | Sep 2001 | NZ | national |
This application is a continuation application of U.S. Ser. No. 10/072,271 filed on Feb. 7, 2002 now U.S. Pat. No. 6,789,541 (now allowed), which is a continuation-in-part of U.S. Ser. No. 09/881,633 filed on Jun. 14, 2001 now U.S. Pat. No. 6,615,834 (now allowed).
Number | Name | Date | Kind |
---|---|---|---|
1081745 | Johnson et al. | Dec 1913 | A |
1356708 | Goodyear | Oct 1920 | A |
1443820 | Hudson | Jan 1923 | A |
2383649 | Heidbrink | Aug 1945 | A |
2414405 | Blerman et al. | Jan 1947 | A |
2444417 | Bierman | Jul 1948 | A |
2675803 | Kaslow | Apr 1954 | A |
2765792 | Nichols | Oct 1956 | A |
2837090 | Bloom et al. | Jun 1958 | A |
3013556 | Galleher, Jr. | Dec 1961 | A |
3065747 | Forkel | Nov 1962 | A |
3079917 | Pate | Mar 1963 | A |
3513844 | Smith | May 1970 | A |
3643660 | Hudson et al. | Feb 1972 | A |
3792702 | Delest | Feb 1974 | A |
3910269 | Ansite et al. | Oct 1975 | A |
3987798 | McGinnis | Oct 1976 | A |
4002167 | Rambosek | Jan 1977 | A |
4106505 | Salter et al. | Aug 1978 | A |
4120300 | Tiep | Oct 1978 | A |
4151843 | Brekke et al. | May 1979 | A |
4235229 | Ranford et al. | Nov 1980 | A |
4414973 | Matheson et al. | Nov 1983 | A |
4459983 | Beyreuther et al. | Jul 1984 | A |
4641647 | Behan | Feb 1987 | A |
4732147 | Fuller | Mar 1988 | A |
4739755 | White et al. | Apr 1988 | A |
4774946 | Ackerman et al. | Oct 1988 | A |
4823789 | Beisang, III | Apr 1989 | A |
4907584 | McGinnis | Mar 1990 | A |
5003632 | Claude | Apr 1991 | A |
5038776 | Harrison et al. | Aug 1991 | A |
5042477 | Lewis | Aug 1991 | A |
5042478 | Kopala et al. | Aug 1991 | A |
5069206 | Crosbie | Dec 1991 | A |
5074295 | Willis | Dec 1991 | A |
5097827 | Izumi | Mar 1992 | A |
5117818 | Palfy | Jun 1992 | A |
5123410 | Greene et al. | Jun 1992 | A |
5146913 | Khorsandian et al. | Sep 1992 | A |
5156641 | White | Oct 1992 | A |
5181507 | Michel et al. | Jan 1993 | A |
5193532 | Moa et al. | Mar 1993 | A |
5237986 | Seppala et al. | Aug 1993 | A |
5243971 | Sullivan et al. | Sep 1993 | A |
5251616 | Desch | Oct 1993 | A |
5271391 | Graves | Dec 1993 | A |
5282463 | Hammersley | Feb 1994 | A |
5383451 | DeIulio | Jan 1995 | A |
5477852 | Landis et al. | Dec 1995 | A |
5513635 | Bedi | May 1996 | A |
5533506 | Wood | Jul 1996 | A |
5537997 | Mechlenburg et al. | Jul 1996 | A |
5542128 | Lomas | Aug 1996 | A |
5570689 | Starr et al. | Nov 1996 | A |
5653228 | Byrd | Aug 1997 | A |
5662101 | Ogden et al. | Sep 1997 | A |
5682881 | Winthrop et al. | Nov 1997 | A |
5687715 | Landis et al. | Nov 1997 | A |
5735272 | Dillon et al. | Apr 1998 | A |
5752510 | Goldstein | May 1998 | A |
5832918 | Pantino | Nov 1998 | A |
5921239 | McCall et al. | Jul 1999 | A |
5975077 | Hofstetter et al. | Nov 1999 | A |
5975079 | Hellings et al. | Nov 1999 | A |
6019101 | Cotner et al. | Feb 2000 | A |
6044844 | Kwok et al. | Apr 2000 | A |
6047699 | Ryatt et al. | Apr 2000 | A |
6192886 | Rudolph | Feb 2001 | B1 |
6338342 | Fecteau et al. | Jan 2002 | B1 |
6374826 | Gunaratnam et al. | Apr 2002 | B1 |
6457473 | Brostrom et al. | Oct 2002 | B1 |
6470886 | Jestrabek-Hart | Oct 2002 | B1 |
6494207 | Kwok | Dec 2002 | B1 |
6520182 | Gunaratnam | Feb 2003 | B1 |
6536435 | Fecteau et al. | Mar 2003 | B1 |
6536436 | McGlothen | Mar 2003 | B1 |
6591837 | Byram | Jul 2003 | B1 |
6612309 | Ancona | Sep 2003 | B1 |
6615834 | Gradon et al. | Sep 2003 | B1 |
6691708 | Kwok et al. | Feb 2004 | B1 |
6701926 | Olsen et al. | Mar 2004 | B1 |
6715490 | Byram | Apr 2004 | B1 |
6796308 | Gunaratnam et al. | Sep 2004 | B1 |
6823869 | Raje et al. | Nov 2004 | B1 |
6840238 | Van Hegelsom | Jan 2005 | B1 |
20020005201 | Gradon et al. | Jan 2002 | A1 |
20030000533 | Olsen et al. | Jan 2003 | A1 |
20030111080 | Olsen et al. | Jun 2003 | A1 |
20040112377 | Amarasinghe et al. | Jun 2004 | A1 |
20040244804 | Olsen et al. | Dec 2004 | A1 |
20050056286 | Huddart et al. | Mar 2005 | A1 |
Number | Date | Country |
---|---|---|
156493 | Jan 1952 | AU |
1084727 | Mar 2001 | EP |
1163924 | Dec 2001 | EP |
WO 8703704 | Jun 1987 | WO |
WO9848876 | Nov 1998 | WO |
WO0189381 | Nov 2001 | WO |
Number | Date | Country | |
---|---|---|---|
20040035428 A1 | Feb 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10072271 | Feb 2002 | US |
Child | 10646434 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09881633 | Jun 2001 | US |
Child | 10072271 | US |